Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angola
100%
Luanda
63%
Human Immunodeficiency Virus Type 1 (HIV-1)
32%
COVID-19
25%
Blood Donors
25%
Risk Factors
24%
Drug Resistance mutations
21%
Antiretroviral Therapy
19%
HIV Patients
19%
Portugal
19%
Newly Diagnosed
18%
Odds Ratio
15%
Seroprevalence
14%
Integrase Strand Transfer Inhibitor (INSTI)
13%
Transmitted Drug Resistance
13%
Drug Resistance
13%
HIV Drug Resistance
12%
Next-generation Sequencing
12%
Hepatitis B Virus Infection
11%
Transmission Cluster
11%
Sexually Transmitted Infections
11%
Nave
11%
Hepatitis B Virus
10%
HIV Transmission
9%
People Living with HIV (PLHIV)
9%
Africa
8%
Healthy Blood Donors
8%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
8%
Public Health Risk
7%
Men Who Have Sex with Men
7%
Co-infection
7%
Blood Group
7%
Molecular Epidemiology
7%
Brazil
7%
Donor Candidate
6%
Sub-Saharan Africa
6%
Adult Patients
6%
Mozambique
6%
Genomic Surveillance
6%
Syphilis
6%
PALOP
6%
Portuguese-speaking African Countries
6%
HIV-1 Diversity
6%
Migrants
6%
Behavioral Factors
6%
Malaria
6%
Epidemiological Characteristics
6%
Healthcare Professionals
6%
Genetic Diversity
6%
Sociodemographic Characteristics
6%
Medicine and Dentistry
Human immunodeficiency virus
52%
Drug Resistance
36%
Blood Donor
20%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Infection
16%
Odds Ratio
15%
Hepatitis B Virus
13%
Resistance Mutation
12%
Hepatitis B
12%
Next Generation Sequencing
12%
Mixed Infection
9%
Seroprevalence
8%
Nonnucleoside Reverse Transcriptase Inhibitor
8%
Reverse-Transcriptase Inhibitor
8%
Public Health
8%
COVID-19
7%
Proteinase
7%
Health Care Cost
7%
Men Who Have Sex with Men
7%
Antiretroviral Therapy
7%
Molecular Epidemiology
6%
Integrase
6%
Blood Transfusion
6%
Syphilis
6%
Virus
6%
Dengue Virus
6%
Rotavirus
5%
Drug Resistant Tuberculosis
5%
Rotavirus Vaccine
5%
Integrase Inhibitor
5%
Blood Group ABO System
5%
Tuberculostatic Agent
5%
Serotype
5%
Vector Borne Disease
5%
Sickle Cell Trait
5%
Clinical Feature
5%
Zika virus
5%
Outbreak Investigation
5%
Maturation
5%
Cross Sectional Study
5%